• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>Cancers >Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer—How Low-Cost Must MRI Be?
【2h】

Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer—How Low-Cost Must MRI Be?

机译：数字乳房Tomosynthesis的成本效益与缩写乳腺MRI用于筛查患有乳腺癌中间风险的妇女 - 有多低成本必须是MRI？

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Women with dense breasts have an increased risk of breast cancer and a smaller likelihood of detection in conventional mammographic screening. It is an ongoing challenge of breast imaging techniques to increase sensitivity in dense breasts. Tomosynthesis, as well as abbreviated breast MR, intends to close the gap between optimal cancer detection rate and cost-effectiveness. The aim of this economic evaluation was to analyse the cost-effectiveness of these two imaging techniques in screening women of intermediate risk of breast cancer due to dense breasts. The model-based analysis revealed that abbreviated breast MRI can be considered cost-effective, being below the willingness to pay-threshold of $100,000 per quality-adjusted life-year gained.
机译：患有浓密乳腺癌的妇女具有较高的乳腺癌风险以及常规乳房X线监测筛查中的检测较小可能性。乳房成像技术是一种持续的挑战，以提高密集乳房的敏感性。 Tomos合成以及缩写的乳房MR，打算缩小最佳癌症检测率和成本效益之间的差距。这种经济评估的目的是分析这两种成像技术的成本效益在筛选由于浓密的乳腺癌患乳腺癌的中间风险的妇女。基于模型的分析显示，缩写乳房MRI可以被认为是成本效益的，低于支付速度的愿意，每年一个质量调整的生命年份获得100,000美元。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号